Hi All -
Anyone have any insight into the latest in this group? Info seems kind of stale and would really appreciate any help.
Looking for anything on hours (associate), general culture, execution experience, and any WLB initiatives? Seems like they may be hiring but is it to replenish turnover or to right size the staffing?
Thank you in advance!
| +384 | Evercore Intern Seizure | 59 | 2h |
| +75 | JPM M&A is Gone??? Purely Coverage Banking??? | 35 | 7h |
| +64 | Is DCM actually underrated ? | 27 | 6h |
| +53 | How do I understand vs. just memorizing? | 10 | 2h |
| +48 | Losing my personality in Banking | 9 | 1d |
| +42 | Associate & Above IB exits | 17 | 1h |
| +37 | The good and bad with Wells Fargo | 7 | 5h |
| +33 | Incoming IB Analyst: Best Ways to Prepare? | 11 | 17h |
| +29 | Tech to IB Pivot | 20 | 6h |
| +27 | Which groups are ideal for laterals? | 12 | 1d |
Career Resources
Get instant access to lessons taught by experienced private equity pros and bulge bracket investment bankers including financial statement modeling, DCF, M&A, LBO, Comps and Excel Modeling.
Can speak a bit to the group; really nice people and genuinely theyre helpful to juniors.
BofA deez nuts
I say this meaning only to inform, so will only go with facts:
This is really helpful. Thank you! Anything that’s driving the higher turnover (other than high hours?).
This seems like a really sweaty role - but HC across the street is pretty sweaty right now.
They don’t have a good healthcare services space? It looked like they did OK
Honestly not sure where the above comes from. Medtech is the smallest vertical in HC IBK and there's a ton of HCIT/lifesciences stuff
This is pretty off. Med Tech team lost all its luster when the core guys went to Guggenheim. Since then might have done one or two M&A deals? Mostly been equity focused and one of the 3 MDs recently left. Lot of the IPOs are actually because of the research analyst with very strong reputation.
Pharma also used to be very ipo focused but had some good runs with large deals. But one of the guys on Ny and key guy in SF recently left so you really have one key MD which is light. Bunch of the historic deals also actually got done out of London and SF.
services used to be legacy strength of the group. Most of the people are gone and activity especially in M&A is less than it used to be. Was doing well with HCIT recently, but that MD also left.
on BB world, well behind JPM, GS, Barclays and MS. Probably not much worse than CS. Tbh used to be top 2/3 but lost some luster over the years.
Can't speak to the rest, but in relation to what you said on BB - actually untrue if you look at a league table
-
What’s the return offer rate for this group?
Any updates on this? How are the hours?
Ut rem rem voluptatibus placeat. Illo eum in voluptatibus et sunt et. Saepe delectus distinctio odio odio optio sunt modi. Vero vel ut tempora odit. Aut deleniti et qui voluptatem doloribus mollitia. Fugit alias quis dolorem adipisci tenetur eos ut.
Quaerat et dolorem consectetur ipsam sed facere non. Laborum magni et nemo earum molestiae. Velit quibusdam earum repudiandae officia. Aliquam officia minima est cumque tempora est ut. Pariatur at maiores porro quasi quia.
Odit id praesentium nulla in qui ut. Et maxime harum consequatur ipsum ipsum sunt expedita.
See All Comments - 100% Free
WSO depends on everyone being able to pitch in when they know something. Unlock with your email and get bonus: 6 financial modeling lessons free ($199 value)
or Unlock with your social account...